Private investor evening details19 Feb 2026 07:28
Private Investor Evening: 25 February 2026 - Ilika, Poolbeg Pharma, Kelso, First Tin
Wed 25 Feb | London
Join other private investors in person at this Yellowstone Advisory Private Investor Evening to hear the investment case from a number of listed companies. Each company will present for 15-20 minutes followed by 5 minutes of Q&A.
Time & Location
25 Feb 2026, 17:30 – 20:00
London, 25 Charterhouse Square, London EC1M 6AE, UK
About the event
Join other private investors in person at this Yellowstone Advisory Private Investor Evening to hear the investment case from a number of listed companies. Each company will present for 15-20 minutes followed by 5 minutes of Q&A. There will then be an opportunity to have further discussions with the different management teams over drinks and canapes.
The companies presenting are: Ilika, Poolbeg Pharma, First Tin
Ilika, Graeme Purdy, Chief Executive Officer
Ilika is a global expert in the development of solid-state battery technology for electric vehicles, medical devices and consumer appliances. The Company's pioneering next-generation technologies aim to provide scalable, affordable alternatives to conventional batteries, to industries which need to incorporate a smaller, lighter, and safer power source in their products. The Company has two product lines. Its Stereax batteries are designed for powering miniature medical implants, industrial wireless sensors and Internet of Things (IoT) applications and the Goliath large format batteries are designed for EV cars and cordless appliances. Through its licensing business model, Ilika supplies its IP portfolio to both OEMs and manufacturing partners in exchange for a license fee and future royalties. Stereax is licensed to US-headquartered medical device manufacturer Cirtec Medical.